Page 19 of 19

January 16, 2006

January 16, 2006

As the Times series has amply shown, our health suffers when we rely on fast foods and sugary drinks to sustain ourselves. But in places where malnourishment and poverty are rampant, the ramifications are even more profound.

In Western countries the transition from hardscrabble malnourishment to today’s drive-through, fast-food cornucopia occurred over centuries, with the happy result that our societies were able to control infectious diseases spread by hunger and poverty before facing the maladies of richly calorific diets, including diabetes, obesity and heart disease. As anyone who has seen the KFCs and Pizza Huts sprouting along the alleys of Mumbai and Cape Town knows, in developing countries, no such time lag exists. What experts call the “nutrition transition” is taking place within a single generation.

According to recent research, malnourished mothers tend to bear babies predisposed to storing excess energy as fat. This is a useful adaptive advantage in communities where calories are often scarce, enabling babies to survive nutritional deficits. But when such babies grow up to consume Western-style diets chock-full of fatty, sugary foods, that benefit turns into a deadly curse, leading them to gain disease-causing extra fat much more rapidly than they would have otherwise. And so, hot on the heels of the multinational soft drink and fast food companies in poor countries has been an epidemic of chronic disease.Today, four of out five people who die of chronic, noncommunicable diseases such as diabetes and heart disease perish not in New York or California but in developing countries, according to the World Health Organization. More Indians and Chinese suffer cardiovascular disease than Americans, Japanese, and Europeans put together.

Diabetes and coronary heart disease are epidemic in India, which is home to the greatest concentration of Type II diabetes sufferers in the world. In some areas of Africa, as many as one in five has diabetes. Nearly 20 million Africans suffer from hypertension. Worse, while diabetes in rich countries is primarily a condition of the elderly, in developing countries the disease strikes those in the prime of life, aged forty-five to sixty-five, slashing their average life expectancy by ten to fifteen years. For developing countries barely treading water amid the flood of malnutrition, HIV infection, malaria, and tuberculosis, “the public health implications of this phenomenon are staggering,” the WHO has noted, “and are already becoming apparent.”

The era of strings-attached IMF and World Bank loans, which forced the dismantling of many indebted countries’ public-health infrastructures, is partly to blame. Global trade agreements forged throughout the 1990s eased the entry of soda makers and fast-food companies into the emerging markets of the developing world. As we start to address the deadly legacy of hyper-marketed fast foods and sodas here at home, we should remember that the problem does not end at the corner Burger King. We’ve spread the problem beyond our borders, where its effect is likely to be much worse.

EPA on pesticide testing

Proving pesticides are safe by testing them on humans is harder than proving them safe by testing on animals, so the new standards are actually higher, not lower–i.e. more likely to protect public health! so long as pesticides are being used, i think it is good that the EPA is requiring human testing. why should chemical companies get off with animal testing alone? we’re all exposed to pesticides all the time. either prove the stuff safe for humans or get rid of it altogether, i say.

The politics of international aid

Aid is a potent drug. It can help or hinder, depending on the circumstances. If you don’t have cancer, for example, a cancer drug will kill you. That’s why the maxim that is meant to guide medicine is to first do no harm. Don’t rush to “help” because your help (being faulty, partial, subjective) could very well be hurtful. First, just don’t actively hurt the patient. So what does that mean for aid in Africa? Debating the pros and cons of “help” is premature. First, let’s stop actively hurting the place: despoiling West Africa for oil; logging rainforests; exploitative mining; dumping toxic waste and cheap, unsellable goods and all the rest of it.

New cornucopian book….

Enviro Bill McKibben has written a new book which, according to Publishers Weekly “contends that there is no boundary to human ambition or desire or to what our very inventions may make possible.” Bill McKibben is very smart and writes beautifully–and I haven’t read his new book-but I have an opinion anyway. (A bad habit I picked up working as an editor for 10 years.) It seems to me that a lot of these alarms about the high-tech future are misplaced. We still have 2 billion people on the planet who don’t have electricity or running water! How far can a few biotech companies and their ultra-elite customers (certainly in a global sense) get with resource-intensive robotics and nanotechnology while the rest of the world descends into conflicts over resource scarcity amid an abruptly changing climate?

Genetically modified mosquitoes?

To think that we could develop a man-made mosquito–our own super-mozzie– more adept than those in the wild, with their great diversity of habits and lifestyles greatly underestimates the wiliness of these dappled flies.
Stalked by pathogens, needed by no creature, these insects have neverthless thrived for over 100 million years, in almost every place where the sun shines and the rain falls, however seldom. They’re good at it. Some GM mosquito might beat a few out, in some places, at some times, but they couldn’t win everywhere. As with DDT, there’s no one-size-fits-all solution to malaria, try as we might to find one.

GM mosquitoes!

The news media is in a big kerfuffle over reports of a new geneticallymodified mosquito that is resistant to malaria, and all the strongerthan wild mosquitoes for it. Sounds perfect, right? Stronger bugs thatfight off the parasite would easily eclipse the local weaklings thatfall prey, and soon enough, there’d be no more malaria.
And yet…each malarial locale is as unique as a snowflake, withparasites specifically adapted to local mosquitoes, which are of acertain breed, a just-so strain, with their own uniquely finickyhabits. There are over a dozen different species of Anophelesmosquitoes that effectively transmit human malaria. Some thrive inshady running water, some in still sunny puddles, others in saltymarshes, some in forests, others in deserts. Some bite at night, othersat dusk, some feed on cows and horses, others solely on humans. We knowprecious little about this great diversity of anopheline habits, andcan barely tell the critters apart, but genetic studies tell us thatthey’re continuing to break into ever more species. Even as I write,wild malarial mosquitoes are transforming themselves to more fullyexploit their local environs, like water to a cup, in ways we can onlydimly grasp.
To think, then, that we could develop our own mosquito, one thatwould be stronger and more adept in all of these specific localhabitats–our own super-mozzie–greatly underestimates the resilienceof these dapple-winged flies. The GM mosquitoes currently developed arejust a proof-of-concept, and they’ve been tested only against mousemalaria, but even if their development progressed, they could onlyconceivably work in some places, at some times. They couldn’t workeverywhere. Just as with DDT, there’s no one-size-fits-all, try as wemight to find one.

Nigeria out to arrest Pfizer execs

According to the BBC, the Nigerian authorities have now issued warrants for the arrest of several Pfizer staffers! Their case against Pfizer, regarding the botched 1996 Trovan trial on meningitis patients, has been preposterously slow. There are several lawsuits pending and all have been adjourned, postponed, delayed etc etc more than twice. This latest twist probably has more to do with intensifying pressure on the much more important–but less talked about–settlement talks, which have been ongoing throughout in London.

The Nigerian authorities aren’t after greater transparency in clinical trials, which would go a long way toward preventing the kinds of violations that occurred in the Trovan trial. They’re dialing for dollars. Can’t blame them, exactly, but it hardly advances the cause.

Newer posts »

© 2025 Sonia Shah

Site by NormanUp ↑